We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Data Needed Before Beginning Phase II Antibacterial Trials
Data Needed Before Beginning Phase II Antibacterial Trials
September 30, 2009
Sponsors should consider a range of factors in determining the types of infections their systemic antibacterial products will treat and submit results from nonclinical studies before beginning Phase II clinical trials, a new draft guidance says.